Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) reported Q1 EPS of ($0.52), $0.01 better than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Olema Pharmaceuticals, Inc. (OLMA) click here.